GB9810920D0 - Therapeutic use - Google Patents

Therapeutic use

Info

Publication number
GB9810920D0
GB9810920D0 GBGB9810920.0A GB9810920A GB9810920D0 GB 9810920 D0 GB9810920 D0 GB 9810920D0 GB 9810920 A GB9810920 A GB 9810920A GB 9810920 D0 GB9810920 D0 GB 9810920D0
Authority
GB
United Kingdom
Prior art keywords
therapeutic use
therapeutic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB9810920.0A
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Organon Pharma UK Ltd
Original Assignee
Merck Sharp and Dohme Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck Sharp and Dohme Ltd filed Critical Merck Sharp and Dohme Ltd
Priority to GBGB9810920.0A priority Critical patent/GB9810920D0/en
Publication of GB9810920D0 publication Critical patent/GB9810920D0/en
Priority to EP99922393A priority patent/EP1079863A1/en
Priority to CA002327585A priority patent/CA2327585A1/en
Priority to JP2000549299A priority patent/JP2002515461A/ja
Priority to PCT/GB1999/001632 priority patent/WO1999059635A1/en
Priority to AU39486/99A priority patent/AU758983B2/en
Priority to US10/614,389 priority patent/US20040097573A1/en
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/06—Antigout agents, e.g. antihyperuricemic or uricosuric agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Rheumatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Pain & Pain Management (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
GBGB9810920.0A 1998-05-21 1998-05-21 Therapeutic use Ceased GB9810920D0 (en)

Priority Applications (7)

Application Number Priority Date Filing Date Title
GBGB9810920.0A GB9810920D0 (en) 1998-05-21 1998-05-21 Therapeutic use
EP99922393A EP1079863A1 (en) 1998-05-21 1999-05-19 Use of a cox-2 inhibitor and a nk-1 receptor antagonist for treating inflammation
CA002327585A CA2327585A1 (en) 1998-05-21 1999-05-19 Use of a cox-2 inhibitor and a nk-1 receptor antagonist for treating inflammation
JP2000549299A JP2002515461A (ja) 1998-05-21 1999-05-19 炎症治療へのｃｏｘ−２阻害薬およびｎｋ−１受容体拮抗薬の使用
PCT/GB1999/001632 WO1999059635A1 (en) 1998-05-21 1999-05-19 Use of a cox-2 inhibitor and a nk-1 receptor antagonist for treating inflammation
AU39486/99A AU758983B2 (en) 1998-05-21 1999-05-19 Use of a COX-2 inhibitor and a NK-1 receptor antagonist for treating inflammation
US10/614,389 US20040097573A1 (en) 1998-05-21 2003-07-07 Use of a COX-2 inhibitor and a NK-1 receptor antagonist for treating inflammation

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB9810920.0A GB9810920D0 (en) 1998-05-21 1998-05-21 Therapeutic use

Publications (1)

Publication Number Publication Date
GB9810920D0 true GB9810920D0 (en) 1998-07-22

Family

ID=10832454

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB9810920.0A Ceased GB9810920D0 (en) 1998-05-21 1998-05-21 Therapeutic use

Country Status (6)

Country Link
EP (1) EP1079863A1 (ja)
JP (1) JP2002515461A (ja)
AU (1) AU758983B2 (ja)
CA (1) CA2327585A1 (ja)
GB (1) GB9810920D0 (ja)
WO (1) WO1999059635A1 (ja)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1492784A4 (en) 2002-03-28 2006-03-29 Merck & Co Inc SUBSTITUTED 2,3-DIPHENYLPYRIDINES
KR20040072004A (ko) 2003-02-07 2004-08-16 삼성에스디아이 주식회사 유기 전계 발광 소자용 발광 화합물 및 그를 이용한 유기전계발광 소자
EP2266585B1 (en) 2003-05-07 2013-06-26 Osteologix A/S Water-soluble strontium salts for use in treatment of cartilage and/or bone conditions
WO2006081088A2 (en) * 2005-01-24 2006-08-03 Pozen Inc. Compositions and therapeutic methods utilizing a combination of a protein extravasation inhibitor and an nsaid

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL106142A (en) * 1992-06-29 1997-03-18 Merck & Co Inc Morpholine and thiomorpholine tachykinin receptor antagonists, their preparation and pharmaceutical compositions containing them
GB2287404A (en) * 1994-03-15 1995-09-20 Pfizer Antiinflammatory and analgesic compositions
KR100517210B1 (ko) * 1994-12-12 2006-06-07 오메로스 코포레이션 통증,염증및경련억제용관주용액
GB9426103D0 (en) * 1994-12-23 1995-02-22 Merck Sharp & Dohme Therapeutic agents
AU5276696A (en) * 1995-04-04 1996-10-23 Glaxo Group Limited Imidazo{1,2-a}pyridine derivatives
WO1997025988A1 (en) * 1996-01-17 1997-07-24 Eli Lilly And Company Methods of treating or preventing pain or nociception
EA001472B1 (ru) * 1996-08-14 2001-04-23 Джи. Ди. Сирл Энд Ко. Кристаллическая форма 4-[5-метил-3-фенилизоксазол-4-ил]бензолсульфонамида
US5750549A (en) * 1996-10-15 1998-05-12 Merck & Co., Inc. Cycloalkyl tachykinin receptor antagonists

Also Published As

Publication number Publication date
AU3948699A (en) 1999-12-06
WO1999059635A1 (en) 1999-11-25
EP1079863A1 (en) 2001-03-07
JP2002515461A (ja) 2002-05-28
CA2327585A1 (en) 1999-11-25
AU758983B2 (en) 2003-04-03

Similar Documents

Publication Publication Date Title
GB9820113D0 (en) Therapeutic agents
GB9816263D0 (en) Therapeutic agents
GB9806102D0 (en) Therapeutic agents
GB9804885D0 (en) Therapeutic combination
GB9808663D0 (en) Therapeutic agents
GB9801234D0 (en) Therapeutic agents
GB9813576D0 (en) Therapeutic agents
GB9813006D0 (en) Therapeutic agents
GB9801210D0 (en) Therapeutic agents
AP9901436A0 (en) Therapeutic agents
GB9801397D0 (en) Therapeutic agents
GB9801202D0 (en) Therapeutic agents
GB9810092D0 (en) Therapeutic agents
GB9819484D0 (en) Therapeutic agents
GB9811879D0 (en) Therapeutic agents
GB9810920D0 (en) Therapeutic use
GB9816897D0 (en) Therapeutic use
GB9812662D0 (en) Therapeutic use
GB9815317D0 (en) Therapeutic agents
GB9817838D0 (en) Therapeutic agents
GB9805716D0 (en) Therapeutic agents
GB9821179D0 (en) Therapeutic use
GB9811624D0 (en) Therapeutic use
GB9816723D0 (en) Therapeutic agents
GB9812664D0 (en) Therapeutic use

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)